Literature DB >> 7619901

Comparison of polymerase chain reaction and virus isolation for detection of epizootic hemorrhagic disease virus in clinical samples from naturally infected deer.

I E Aradaib1, G Y Akita, J E Pearson, B I Osburn.   

Abstract

We compared our recently reported reverse transcriptase polymerase chain reaction (PCR)-based assay for detection of epizootic hemorrhagic disease virus (EHDV) in clinical samples with different virus isolation (VI) procedures. Thirty-six blood samples and 1 spleen sample from deer were assessed by the EHDV PCR assay and VI in baby hamster kidney (BHK)-21 cells and embryonated chicken eggs (ECE). The EHDV PCR assay detected EHDV RNA from 6 blood samples obtained from deer during 1988-1989 outbreaks of epizootic hemorrhagic disease and from the spleen and blood samples of a deer with clinical hemorrhagic disease in 1992. The 6 blood samples from the 1988-1989 outbreaks and the spleen sample from the 1992 case were VI positive on BHK-21 cell culture. The blood from the same deer with the PCR- and VI-positive spleen was VI negative in BHK-21 cells and ECE. All EHDV isolates were identified as EHDV serotype 2 by a plaque inhibition test. The results of this study indicate that the sensitivity of the previously described EHDV PCR assay is comparable to or greater than that of the VI method in BHK-21 cell culture or ECE. The EHDV PCR assays could provide a superior diagnostic alternative to the current cumbersome and time-consuming VI procedures.

Entities:  

Mesh:

Year:  1995        PMID: 7619901     DOI: 10.1177/104063879500700205

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  8 in total

1.  A simple and rapid method for detection of African horse sickness virus serogroup in cell cultures using RT-PCR.

Authors:  I E Aradaib; M E H Mohemmed; J A Sarr; S H Idris; N O M Ali; A A Majid; A E Karrar
Journal:  Vet Res Commun       Date:  2006-04       Impact factor: 2.459

2.  PCR detection of North American and Central African isolates of epizootic hemorrhagic disease virus (EHDV) based on genome segment 10 of EHDV serotype 1.

Authors:  I E Aradaib; W C Wilson; C E Schore; M E Mohammed; T D Yilma; J S Cullor; B I Osburn
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

3.  RT-PCR assays for seven serotypes of epizootic haemorrhagic disease virus & their use to type strains from the Mediterranean region and North America.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Donna J Johnson; Mehdi El Harrak; Hafsa Madani; Hagai Yadin; Serife Incoglu; Kadir Yesilbag; Andrew B Allison; David E Stallknecht; Carrie Batten; Simon J Anthony; Peter P C Mertens
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

4.  Development of polymerase chain reaction for specific identification of epizootic hemorrhagic disease virus serotype 1.

Authors:  I E Aradaib; J W McBride; W C Wilson; B I Osburn
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Prevalence of bluetongue virus antibodies and associated risk factors among cattle in East Darfur State, Western Sudan.

Authors:  Hadia Om Khair; Ibrahim A Adam; Shakir B Bushara; Kamal H Eltom; Nasreen O Musa; Imadeldin E Aradaib
Journal:  Ir Vet J       Date:  2014-02-07       Impact factor: 2.146

6.  Prevalence of bluetongue virus infection and associated risk factors among cattle in North Kordufan State, Western Sudan.

Authors:  Ibrahim A Adam; Mohamed A Abdalla; Mohamed E H Mohamed; Imadeldin E Aradaib
Journal:  BMC Vet Res       Date:  2014-04-24       Impact factor: 2.741

Review 7.  Detection of animal pathogens by using the polymerase chain reaction (PCR).

Authors:  J M Rodriguez
Journal:  Vet J       Date:  1997-05       Impact factor: 2.688

8.  Development of Real-Time RT-PCR Assays for Detection and Typing of Epizootic Haemorrhagic Disease Virus.

Authors:  N S Maan; S Maan; A C Potgieter; I M Wright; M Belaganahalli; P P C Mertens
Journal:  Transbound Emerg Dis       Date:  2016-02-17       Impact factor: 5.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.